Journal of the American College of Surgeons
Volume 196, Issue 3 , Pages 365-369 , March 2003

Octreotide in the treatment of lymphorrhea after axillary node dissection: a prospective randomized controlled trial

  • Paolo Carcoforo, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Giorgio Soliani, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Umberto Maestroni, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • A Donini, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Daniel Inderbitzin, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Thomas T Hui, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Alan Lefor, MD, MPH, FACS

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • ,
  • Itzhak Avital, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA
    • Corresponding Author InformationCorrespondence address: Itzhak Avital, MD, Cedars-Sinai Medical Center, Department of Surgery, 8700 Beverly Blvd, Davis 4005, Los Angeles, CA 90048, USA
    • ,
  • Giuseppe Navarra, MD

      Affiliations

    • University of Ferrara, Department of Biomedical Sciences and Advanced Therapy, General Surgery Division (Carcoforo, Soliani, Maestroni, Donini, Navarra), Ferrara, Italy
    • Cedars-Sinai Medical Center, Department of Surgery, UCLA School of Medicine (Inderbitzin, Hui, Lefor, Avital), Los Angeles, CA, USA

Received 8 March 2001 ,Revised 3 October 2002 ,Accepted 22 October 2002.

References 

  1. Roses DF, Harris MN, Potter DA, Gumport SL. Total mastectomy with complete axillary dissection. Ann Surg. 1981;194:4–8
  2. Carcoforo P, Anania G. Complicanze precoci in chirurgia mammaria. “La Mammela operata per carcinoma.”. Gnocchi Ed. 1998;1:73–77
  3. Tadych K, Donegan WL. Postmastectomy seromas and wound drainage. Surg Gynecol Obstet. 1987;165:483–487
  4. Say CC, Donegan W. A biostatistical evaluation of complications from mastectomy. Surg Gynecol Obstet. 1974;138:370–376
  5. Alvandy LJ. Preliminary results of conservative treatment of early breast cancer with axillary dissection and post operative radiotherapy. A retrospective review of 107 patients. Aust NZ J Surg. 1991;9:670–674
  6. Osteen RT, Karnell LH. The National Cancer Data Base report on breast cancer. Cancer. 1994;73:1994–2000
  7. Nichter LS, Morgan RF, Dufresne CR, et al.  Rapid management of persistent seromas by sclerotherapy. Ann Plast Surg. 1983;158:233–236
  8. Hayes JA, Bryan RM. Wound healing following mastectomy. Aust NZ J Surg. 1984;54:25–27
  9. Aitken DR, Hunsaker R, James AG. Prevention of seromas following mastectomy and axillary dissection. Surg Gynecol Obstet. 1984;158:327–330
  10. Kulber DA, Bacilious N, Peters ED, et al.  The use of fibrin sealant in the prevention of seromas. Plast Reconstr Surg. 1997;99:842–849
  11. Lotze MT, Duncan MA, Gerber LH, et al.  Early versus delayed shoulder motion following axillary dissection (a randomized prospective study). Ann Surg. 1981;193:288–295
  12. Fillipetti M, Santoro E, Graziano F, et al.  Modern therapeutic approaches to postmastectomy brachial lymphedema. Microsurgery. 1994;15:604–610
  13. Jeffrey SS, Goodson WH, Ideda DM, et al.  Axillary lymphadenectomy for breast cancer without axillary drainage. Arch Surg. 1995;130:909–912
  14. Kutz K, Nuesch E, Rosenthaler J. Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol. 1986;119:65–72
  15. Lamberts SW, Oosterom R, Neufeld M, del Pozo E. The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. J Clin Endocrinol Metab. 1985;60:1161–1165
  16. Harris AG. Future medical prospects for Sandostatin. Metabolism. 1990;39(Suppl 2):180–185
  17. Ulibarri JI, Sanz Y, Fuentes C, et al.  Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet. 1990;336:258
  18. Ramos SM, O’Donnell LS, Knight G. Edema volume, not timing, is the key to success in lymphedema treatment. Am J Surg. 1999;187:311–315
  19. Roses DF, Brooks AD, Harris MN, et al.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg. 1999;320:194–201
  20. Porter KA, O’Connor S, Rimm E, Lopez M. Electrocautery as a factor in seroma formation following mastectomy. Am J Surg. 1998;176:8–11
  21. Albert R, Marbach P, Bauer W, et al.  SDZ CO 611 (a highly potent glycated analog of somatostatin with improved oral activity). Life Sci. 1993;53:517–525

☆ No competing interests declared.

PII: S1072-7515(02)01757-X

doi: 10.1016/S1072-7515(02)01757-X

Journal of the American College of Surgeons
Volume 196, Issue 3 , Pages 365-369 , March 2003

Article Tools